Motley Fool Australia

AstraZeneca (LSE: AZN) Share Price and News

AstraZeneca (LSE: AZN) Latest News

People marching and holding up anti covid vaccine signs

Only 40% of Australians want the AstraZeneca vaccine. What could this mean for CSL (ASX:CSL)?

More »

4 healthcare share tips from a fundie with a health PhD

More »

asx share price rebound represented by wooden blocks spelling rebound with coins on top

Why the CSL (ASX:CSL) share price has rebounded 13% since March

More »

woman waering face mask holding vial of covid-19 vaccine

Wesfarmers’ (ASX:WES) Bunnings open to hosting COVID vaccine hubs

More »

Medical asx share price fall represented by worried looking patient awaiting vaccine injection

CSL (ASX:CSL) share price dips on latest AstraZeneca news

More »

common investors mistakes represented by man looking sheepish

CSL (ASX:CSL) share price wobbles on COVID vaccine news

More »

woman waering face mask holding vial of covid-19 vaccine

AstraZeneca COVID-19 vaccine trial data results in revised efficacy rate

More »

doctor making thumbs up gesture and holding vial labelled 'covid-19 vaccine' representing covid shares

CSL (ASX:CSL) share price up after AstraZeneca vaccine approved for use in Australia

More »

About AstraZeneca (LSE: AZN)

AstraZeneca plc (LSE: AZN) is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas – Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.